Asclera
- Product NDC
- 46783-221
- 11-digit product format
- 467830221
- Labeler code
- 46783
- Product ID
- 46783-221_c8898bed-e13f-40c0-94aa-bd8bbe89f4ce
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- POLIDOCANOL
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Merz North America, Inc
- Application
- NDA021201
- Marketing category
- NDA
- Marketing start
- 2010-06-01
- Marketing end
- 2022-08-31
- Substance
- POLIDOCANOL
- Active strength
- 0 g/mL
- Pharmacologic classes
- Sclerosing Agent [EPC],Sclerosing Activity [MoA],Vascular Sclerosing Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 46783-221-52 | 46783022152 | 2 mL in 1 AMPULE (46783-221-52) | 2 ml | 2010-06-01 | 2022-08-31 | No | No | Current |